Concepedia

Wenbin An

WA

Statistics

Publications

12

Citations

264

H-Index

11

Active since

2014

Affiliations

Institute of Hematology & Blood Diseases Hospital(Current)

Chinese Academy of Medical Sciences & Peking Union Medical College

Memorial Sloan Kettering Cancer Center

Wenbin An is an author at Institute of Hematology & Blood Diseases Hospital specializing in medicine, genetics, and life sciences.

ORCID

Publications per year

2014–2024

12

Publications

12

Intron 1 GATA site enhances ALAS2 expression indispensably during erythroid differentiation

Yingchi Zhang, Jingliao Zhang, Wenbin An et al. · Nucleic Acids Research · 2016 · 46 citations · Full text

, , +14

BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation

Bing Li, Wenbin An, Hua Wang et al. · Blood · 2022 · 35 citations · Full text

, , +15

Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms

Andrew Dunbar, Robert L. Bowman, Young C. Park et al. · Cancer Discovery · 2024 · 30 citations · Full text

, , +16

CALR mutation screening in pediatric primary myelofibrosis

Wenbin An, Yang Wan, Ye Guo et al. · Pediatric Blood & Cancer · 2014 · 25 citations

, , +17

Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial

Li Zhang, Yao Zou, Yumei Chen et al. · BMC Cancer · 2018 · 22 citations · Full text

, , +17

1–5 of 12